2,4,6-trifluorophenylacetic acid ethyl ester | 835878-81-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2,4,6-trifluorophenylacetic acid ethyl ester
• 英文别名: ethyl 2,4,6-trifluorophenylacetate；ethyl 2-(2,4,6-trifluorophenyl)acetate
• CAS: 835878-81-4
• 化学式: C₁₀H₉F₃O₂
• 分子量: 218.175
• InChiKey: YNRBMAMRMQJKBW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2,4,6-trifluorophenylacetic acid ethyl ester 在 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 lithium hexamethyldisilazane 、 三氯氧磷 作用下， 以 四氢呋喃 、 N-甲基吡咯烷酮 为溶剂， 反应 8.75h， 生成 4,6-dichloro-2-methyl-5-(2,4,6-trifluorophenyl)pyrimidine
  参考文献：
  名称：

  WO2023/23242

  摘要：

  公开号：
• 作为产物：
  描述：

  2,4,6-三氟苯乙酸 、 碘乙烷 在 potassium carbonate 作用下， 以 二甲基亚砜 为溶剂， 反应 3.0h， 生成 2,4,6-trifluorophenylacetic acid ethyl ester
  参考文献：
  名称：

  6-Aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents

  摘要：

  本发明涉及某些6-芳基-7-卤代咪唑[1,2-a]嘧啶或其药学上可接受的盐以及含有该化合物或其药学上可接受的盐的组合物，其中该化合物是抗癌剂，可通过促进微管聚合来治疗哺乳动物的癌症。本发明还涉及一种治疗或抑制哺乳动物中癌细胞的生长和相关疾病的方法，并进一步提供了一种用于治疗或预防表达多药耐药性（MDR）或因MDR而耐药的癌症肿瘤的方法，该方法包括向所述哺乳动物施用所述化合物或其药学上可接受的盐的有效量。

  公开号：

  US20050065167A1

文献信息

• [EN] COMPOUNDS FOR THE REDUCTION OF ß-AMYLOID PRODUCTION<br/>[FR] COMPOSÉS POUR LA RÉDUCTION DE LA PRODUCTION DE ß-AMYLOÏDE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2012103297A1

  公开（公告）日：2012-08-02

  The present disclosure provides a series of compounds of the formula (I), which modulate β-amyloid peptide (β-ΑΡ) production and are useful in the treatment of Alzheimer's Disease and other conditions affected by β-amyloid peptide (β-ΑΡ) production.

  本公开提供了一系列化合物的公式(I)，这些化合物调节β-淀粉样肽(β-ΑΡ)的产生，并且在治疗阿尔茨海默病和其他受β-淀粉样肽(β-ΑΡ)产生影响的疾病中有用。
• [EN] 6-[(SUBSTITUTED)PHENYL]TRIAZOLOPYRIMIDINES AS ANTICANCER AGENTS<br/>[FR] 6-[(SUBSTITUTEES)PHENYL]TRIAZOLOPYRIMIDINES UTILISEES EN TANT QU'AGENT ANTICANCEREUX
  申请人：WYETH CORP

  公开号：WO2005030775A1

  公开（公告）日：2005-04-07

  This invention relates to certain 6-[(substituted)phenyl]triazolopyrimidine compounds or pharmaceutically acceptable salts thereof, and compositions containing said compounds or pharmaceutically acceptable salts thereof, wherein said compounds are anti-cancer agents useful for the treatment of cancer in mammals. This invention further relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal and further provides a method for the treatment or prevention of cancerous tumors that express multiple drug resistance (MDR) or are resistant because of MDR, in a mammal in need thereof which method comprises administering to said mammal an effective amount of said compounds or pharmaceutically acceptable salts thereof. The present invention relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal in need thereof by promotion of microtubule polymerization which comprises administering to said mammal an effective amount of said compounds and pharmaceutically acceptable salts thereof.

  本发明涉及某些6-[(取代)苯基]三唑吡咯嗪化合物或其药用盐，以及含有所述化合物或其药用盐的组合物，其中所述化合物是对哺乳动物中的癌症具有治疗作用的抗癌剂。本发明还涉及一种治疗或抑制哺乳动物中癌症肿瘤细胞及相关疾病生长的方法，并进一步提供了一种治疗或预防表达多药耐药性（MDR）或因MDR而具有耐药性的癌症肿瘤的方法，该方法包括向该哺乳动物施用所述化合物或其药用盐的有效量。本发明涉及一种通过促进微管聚合来治疗或抑制哺乳动物中癌症肿瘤细胞及相关疾病生长的方法，该方法包括向该哺乳动物施用所述化合物及其药用盐的有效量。
• 6-Aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents
  申请人：Zhang Nan

  公开号：US20050065167A1

  公开（公告）日：2005-03-24

  This invention relates to certain 6-aryl-7-halo-imidazo[1,2-a]pyrimidines or pharmaceutically acceptable salts thereof, and compositions containing said compounds or pharmaceutically acceptable salts thereof, wherein said compounds are anti-cancer agents useful for the treatment of cancer in mammals by promotion of microtubule polymerization. This invention further relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal and further provides a method for the treatment or prevention of cancerous tumors that express multiple drug resistance (MDR) or are resistant because of MDR, in a mammal in need thereof which method comprises administering to said mammal an effective amount of said compounds or pharmaceutically acceptable salts thereof.

  本发明涉及某些6-芳基-7-卤代咪唑[1,2-a]嘧啶或其药学上可接受的盐以及含有该化合物或其药学上可接受的盐的组合物，其中该化合物是抗癌剂，可通过促进微管聚合来治疗哺乳动物的癌症。本发明还涉及一种治疗或抑制哺乳动物中癌细胞的生长和相关疾病的方法，并进一步提供了一种用于治疗或预防表达多药耐药性（MDR）或因MDR而耐药的癌症肿瘤的方法，该方法包括向所述哺乳动物施用所述化合物或其药学上可接受的盐的有效量。
• 6-[(Substituted)phenyl]triazolopyrimidines as anticancer agents
  申请人：Zhang Nan

  公开号：US20050090508A1

  公开（公告）日：2005-04-28

  This invention relates to certain 6-[(substituted)phenyl]triazolopyrimidine compounds or pharmaceutically acceptable salts thereof, and compositions containing said compounds or pharmaceutically acceptable salts thereof, wherein said compounds are anti-cancer agents useful for the treatment of cancer in mammals. This invention further relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal and further provides a method for the treatment or prevention of cancerous tumors that express multiple drug resistance (MDR) or are resistant because of MDR, in a mammal in need thereof which method comprises administering to said mammal an effective amount of said compounds or pharmaceutically acceptable salts thereof. The present invention relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal in need thereof by promotion of microtubule polymerization which comprises administering to said mammal an effective amount of said compounds and pharmaceutically acceptable salts thereof.

  本发明涉及某些6-[(取代)苯基]三唑嘧啶化合物或其药学上可接受的盐，以及含有该化合物或其药学上可接受的盐的组合物，其中该化合物是对哺乳动物癌症治疗有用的抗癌剂。本发明还涉及一种用于治疗或抑制哺乳动物中癌细胞肿瘤的生长和相关疾病的方法，并进一步提供了一种用于治疗或预防因多药耐药（MDR）而表达多重药物抗性的癌性肿瘤的方法，该方法包括向所述哺乳动物中需要的部位注射所述化合物或其药学上可接受的盐的有效量。本发明还涉及一种通过促进微管聚合来治疗或抑制哺乳动物中癌细胞肿瘤的生长和相关疾病的方法，该方法包括向所述哺乳动物中注射所述化合物及其药学上可接受的盐的有效量。
• Aryl-condensed 3-arylpridine compounds and use thereof for controlling pathogenic fungi
  申请人：Wagner Oliver

  公开号：US20060160811A1

  公开（公告）日：2006-07-20

  The present invention relates to bicyclic compounds of general formula I, in which X, Y independently of one another are N or C—R 4 ; n is 1, 2, 3, 4 or 5; R a is halogen, cyano, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkyl, C 1 -C 6 -haloalkoxy, C 2 -C 6 -alkenyl, C 2 -C 6 -alkenyloxy or C(O)R 5 ; R 1 is halogen, cyano, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 8 -cycloalkyl which is optionally mono- or polysubstituted by alkyl and/or halogen, C 5 -C 8 -cycloalkenyl which is optionally mono- or polysubstituted by alkyl and/or halogen, OR 6 , SR 6 or NR 7 R 8 ; R 2 is halogen, cyano, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 8 -cycloalkyl which is optionally mono- or polysubstituted by alkyl and/or halogen, C 5 -C 8 -cycloalkenyl which is optionally mono- or polysubstituted by alkyl and/or halogen, OR 6 , SR 6 or NR 7 R 8 ; R 3 is hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl or C 3 -C 6 -cycloalkyl which is optionally mono- or polysubstituted by alkyl and/or halogen; and the agriculturally acceptable salts of compounds I, plant protection agents, containing at least one compound of general formula I and/or one agriculturally-acceptable salt of I and at least one liquid or solid carrier substance, as well as a method for controlling phytopathogenic fungi.

  本发明涉及通式I的二环化合物，其中X，Y分别独立地为N或C—R4; n为1、2、3、4或5；R为卤素、氰基、C1-C6烷基、C1-C6烷氧基、C1-C6卤代烷基、C1-C6卤代烷氧基、C2-C6烯基、C2-C6烯氧基或C（O）R5；R1为卤素、氰基、C1-C6烷基、C1-C6卤代烷基、C2-C6烯基、C2-C6炔基、C3-C8环烷基，其可以选择性地被烷基和/或卤素单或多取代，C5-C8环烯基，其可以选择性地被烷基和/或卤素单或多取代，OR6，SR6或NR7R8；R2为卤素、氰基、C1-C6烷基、C1-C6卤代烷基、C2-C6烯基、C2-C6炔基、C3-C8环烷基，其可以选择性地被烷基和/或卤素单或多取代，C5-C8环烯基，其可以选择性地被烷基和/或卤素单或多取代，OR6，SR6或NR7R8；R3为氢、C1-C6烷基、C1-C6卤代烷基或C3-C6环烷基，其可以选择性地被烷基和/或卤素单或多取代；以及通式I化合物的农业上可接受的盐、含有至少一种通式I的化合物和/或一种农业上可接受的I的盐和至少一种液体或固体载体物质的植物保护剂，以及一种控制植物病原真菌的方法。